Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Gastroenterology|October 26, 2020
TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinomaStine K Oversoe, Michelle S Clement, Michael H Pedersen, et al.
BMC Cancer|June 16, 2023
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)Louise Skau Rasmussen, Stine B Winther, Inna M Chen, et al.
Acta Oncologica (Stockholm, Sweden)|December 9, 2021
Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancerMorten Ladekarl, Louise Skau Rasmussen, Jakob Kirkegård, et al.
Pancreas|May 21, 2021
Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age: A Nationwide Real-World Danish Registry StudyLouise S Rasmussen, Claus W Fristrup, Benny V Jensen, et al.
Physics and Imaging in Radiation Oncology|December 10, 2021
Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomasCamilla S Byskov, Christian R Hansen, Rikke H Dahlrot, et al.
Clinical and Translational Radiation Oncology|October 27, 2025
Impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in paediatric renal tumours: a SIOP-RTSG radiotherapy committee studyMianyong Ding, Matteo Maspero, Semi Harrabi, et al.
Clinical and Translational Radiation Oncology|January 5, 2026
Reply to comment on impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in paediatric renal tumours: A SIOP-RTSG radiotherapy committeeMianyong Ding, Matteo Maspero, Semi Harrabi, et al.
Acta Oncologica (Stockholm, Sweden)|October 11, 2021
A national study on the inter-observer variability in the delineation of organs at risk in the brainEbbe Laugaard Lorenzen, Jesper Folsted Kallehauge, Camilla Skinnerup Byskov, et al.
BMC Cancer|May 4, 2021
Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoringYoo Young Dominique Lee, Doan Trang Nguyen, Trevor Moodie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2020
Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register studyLouise S Rasmussen, Claus W Fristrup, Benny V Jensen, et al.
Pageof 7